Royce & Associates’s 89bio ETNB Stock Holding History

Royce & Associates’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-226,058	Closed	-$3.32M	–	780
2025 Q3	$3.32M	Hold	226,058	–	–	0.03%	533
2025 Q2	$2.22M	Buy	226,058 +8	+0%	+$66	0.02%	584
2025 Q1	$1.64M	Buy	+226,050	New	+$1.98M	0.02%	619

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royce & Associates's ETNB Position: Q4 2025 in Review

Royce & Associates sold out of 89bio (ETNB) in Q4 2025, closing a stake of 226,058 shares — an estimated $3.32M sold.

Royce & Associates first reported a position in ETNB in Q1 2025 and held it in 3 quarters. The position peaked at $3.32M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Royce & Associates reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Royce & Associates sold 226,058 89bio shares in Q4 2025, an estimated $3.32M.
Royce & Associates first reported a position in 89bio in Q1 2025 and held it in 3 quarters.
Royce & Associates's 89bio position peaked at $3.32M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.